A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma. (Q35616803)
Jump to navigation
Jump to search
scientific article published on 16 May 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma. |
scientific article published on 16 May 2015 |
Statements
A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma (English)
Beatrice Seddon
Michelle Scurr
Zoe Wood
Cerys Propert-Lewis
Cyril Fisher
Adrienne Flanagan
Jonanthan Sunkersing
Roger A'Hern
Jeremy Whelan
1 reference